Advanced search
Publication Cover
Substance Abuse Volume 37, 2016 - Issue 4
Journal homepage
100
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Use of psychotropic drug urine test strips in opiate maintenance therapy: A clinical assessment of its advantages

Caroline Victorri-VigneauDepartment of Clinical Pharmacology, Center for Evaluation and Information on Pharmacodependence, Nantes University Hospital, Nantes, France;EA4275 Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Science, Nantes University, Nantes, FranceCorrespondence[email protected]
, PharmD, PhD,
Morgane RousseletDepartment of Clinical Pharmacology, Center for Evaluation and Information on Pharmacodependence, Nantes University Hospital, Nantes, France;EA4275 Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Science, Nantes University, Nantes, France;Department of Addictology, Nantes University Hospital, Nantes, France
, MSc,
Marie Grall-BronnecEA4275 Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Science, Nantes University, Nantes, France;Department of Addictology, Nantes University Hospital, Nantes, France
, MD, PhD,
Regis BouquiéEA4275 Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Science, Nantes University, Nantes, France;Department of Clinical Pharmacology, Nantes University Hospital, Nantes, France
, PharmD, PhD,
Emeric BelliotDepartment of Clinical Pharmacology, Center for Evaluation and Information on Pharmacodependence, Nantes University Hospital, Nantes, France
, PharmD,
Marylène GuerlaisDepartment of Clinical Pharmacology, Center for Evaluation and Information on Pharmacodependence, Nantes University Hospital, Nantes, France
, PharmD,
Jean-Yves GuilletNantes Addictology Network, Nantes, France
, MD &
Pascale JollietDepartment of Clinical Pharmacology, Center for Evaluation and Information on Pharmacodependence, Nantes University Hospital, Nantes, France;EA4275 Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Science, Nantes University, Nantes, France;Department of Clinical Pharmacology, Nantes University Hospital, Nantes, France
, MD, PhD show all
Pages 584-590 | Published online: 29 Sep 2016

References

  • Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES). Stratégies thérapeutiques pour les personnes dépendantes des opiacés: place des traitements de substitution. Conférence de consensus. 2004. http://www.has-sante.fr/portail/upload/docs/application/pdf/TSO_court.pdf
  • Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS)- Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES). Réduire les mauvaises utilisations des médicaments de substitution des opiacés. Recommandations professionnelles. 2004. http://www.sanpsy.univ-bordeauxsegalen.fr/data/documents/cours_addicto/mauvaises_utilisation_anaes_2004.pdf
  • Direction Générale de la Santé (DGS). Circulaire DGS/SP3/95 N°29 du 31 mars 1995 relative au traitement de substitution pour les toxicomanes dépendants aux opiacés. 1995. http://bdoc.ofdt.fr/doc_num.php?explnum_id=20611
  • Direction Générale de la Santé (DGS). Circulaire DGS/DHOS N°2002/57 du 30 janvier 2002 relative à la prescription de la méthadone par les médecins exerçant en établissement de santé, dans le cadre de l'initialisation d'un traitement de substitution pour les toxicomanes dépendants majeurs aux opiacés. 2002. http://pmb.ofdt.fr/documents_numeriques/LEGI/232.pdf
  • Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS). Initiation et suivi du traitement substitutif de la pharmacodépendance majeure aux opiacés par buprénorphine haut dosage. Mise au point. 2011. http://www.ansm.sante.fr/var/ansm_site/storage/original/application/8439b6cbb654338f7dcd945b2d1f070e.pdf
  • Dolan K, Rouen D, Kimber J. An overview of the use of urine, hair, sweat and saliva to detect drug use. Drug Alcohol Rev. 2004;23:213–217.
  • Dupouy J, Bismuth S, Oustric S, Lapeyre-Mestre M. On-site drugs of abuse urinary screening tests for the management of opiate-addicted patients: a survey among French general practitioners. Eur Addict Res. 2012;18:175–183.
  • Dupouy J, Dassieu L, Bourrel R, et al. Effectiveness of drug tests in outpatients starting opioid substitution therapy. J Subst Abuse Treat. 2013;44:515–521.
  • Moracchini C, Frauger E, Pauly V, Nordmann S, Thirion X, Micallef J. Harm reduction centers (“CAARUD”): privileged places for warning signal detection in addictovigilance. Therapie. 2012;67:437–445.
  • Wilcox CE, Bogenschutz MP, Nakazawa M, Woody G. Concordance between self-report and urine drug screen data in adolescent opioid dependent clinical trial participants. Addict Behav. 2013;38:2568–2574.
  • Bourgine J, Ma LL, Le Boisselier R, et al. [Comparison between analytic and anamnestic data about drug consumption among opiate addicts with substitutes therapy. A feasibility study]. Therapie. 2009;64:269–277.
  • Beck O, Stephanson N, Sandqvist S, Franck J. Detection of drugs of abuse in exhaled breath using a device for rapid collection: comparison with plasma, urine and self-reporting in 47 drug users. J Breath Res. 2013;7:026006.
  • McCarberg BH. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management. Postgrad Med. Nov 2011;123:124–131.
  • Eiden C, Leglise Y, Bertomeu L, et al. New formulation of methadone for opioid dependence in France: acceptability and diversion/misuse liability. Therapie. 2013;68:107–111.
  • Li SJ, Wang D, Zhang J, Zheng J, Chen WX. Development of test strips for rapid buprenorphine detection in vitro. Clin Biochem. 2013;46(12):1093–1098.
  • Piralishvili G, Gamkrelidze I, Nikolaishvili N, Chavchanidze M. Needs assessment and treatment compliance at state opioid substitution treatment programs in Georgia. Georgian Med News. 2013;(214):28–32.
  • Arora A, Williams K. Problem based review: the patient taking methadone. Acute Med. 2013;12:51–54.
  • Dickerson JA, Laha TJ, Pagano MB, O'Donnell BR, Hoofnagle AN. Improved detection of opioid use in chronic pain patients through monitoring of opioid glucuronides in urine. J Anal Toxicol. 2012;36:541–547.
  • Lippi G, Romero A, Cervellin G, Mercadanti M. Unusual false-positive case of urinary screening for buprenorphine. J Clin Lab Anal. 2011;25:244–245.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.